BlackRock’s Pliant Therapeutics PLRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.47M | Sell |
2,130,519
-3,111,240
| -59% | -$3.61M | ﹤0.01% | 3938 |
|
|
2025
Q1 | $7.08M | Buy |
5,241,759
+61,782
| +1% | +$83.4K | ﹤0.01% | 3449 |
|
|
2024
Q4 | $68.2M | Sell |
5,179,977
-38,988
| -0.7% | -$513K | ﹤0.01% | 2251 |
|
|
2024
Q3 | $58.5M | Buy |
5,218,965
+247,326
| +5% | +$2.77M | ﹤0.01% | 2348 |
|
|
2024
Q2 | $53.4M | Buy |
4,971,639
+316,254
| +7% | +$3.4M | ﹤0.01% | 2336 |
|
|
2024
Q1 | $69.4M | Sell |
4,655,385
-146,132
| -3% | -$2.18M | ﹤0.01% | 2231 |
|
|
2023
Q4 | $87M | Buy |
4,801,517
+478,916
| +11% | +$8.67M | ﹤0.01% | 2127 |
|
|
2023
Q3 | $75M | Sell |
4,322,601
-84,219
| -2% | -$1.46M | ﹤0.01% | 2130 |
|
|
2023
Q2 | $79.9M | Buy |
4,406,820
+2,578,692
| +141% | +$46.7M | ﹤0.01% | 2166 |
|
|
2023
Q1 | $48.6M | Buy |
1,828,128
+332,626
| +22% | +$8.85M | ﹤0.01% | 2428 |
|
|
2022
Q4 | $28.9M | Buy |
1,495,502
+126,382
| +9% | +$2.44M | ﹤0.01% | 2783 |
|
|
2022
Q3 | $28.6M | Buy |
1,369,120
+483,034
| +55% | +$10.1M | ﹤0.01% | 2801 |
|
|
2022
Q2 | $7.1M | Sell |
886,086
-812,126
| -48% | -$6.5M | ﹤0.01% | 3589 |
|
|
2022
Q1 | $11.9M | Buy |
1,698,212
+10,338
| +0.6% | +$72.5K | ﹤0.01% | 3403 |
|
|
2021
Q4 | $22.8M | Buy |
1,687,874
+135,882
| +9% | +$1.83M | ﹤0.01% | 3131 |
|
|
2021
Q3 | $26.2M | Sell |
1,551,992
-5,730
| -0.4% | -$96.7K | ﹤0.01% | 3054 |
|
|
2021
Q2 | $45.4M | Sell |
1,557,722
-117,100
| -7% | -$3.41M | ﹤0.01% | 2724 |
|
|
2021
Q1 | $65.9M | Buy |
1,674,822
+819,249
| +96% | +$32.2M | ﹤0.01% | 2411 |
|
|
2020
Q4 | $19.4M | Buy |
855,573
+371,294
| +77% | +$8.44M | ﹤0.01% | 2957 |
|
|
2020
Q3 | $11M | Buy |
484,279
+398,792
| +466% | +$9.03M | ﹤0.01% | 3095 |
|
|
2020
Q2 | $2.78M | Buy |
+85,487
| New | +$2.78M | ﹤0.01% | 3649 |
|